Journal
JOURNAL OF PHARMACOLOGICAL SCIENCES
Volume 101, Issue 3, Pages 256-259Publisher
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1254/jphs.SC0060049
Keywords
spironolactone; angiotensin II; peripheral blood mononuclear cell
Categories
Ask authors/readers for more resources
We evaluated the effect of alacepril, CV-11974, and spironolactone on the production of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha) in cultured human peripheral blood mononuclear cells stimulated with angiotensin (Ang) II. Alacepril, CV-11974, and spironolactone significantly reduced the enhanced production of MCP-1 and TNF-alpha induced by exogenous Ang II. Specifically, 10 mu M of spironolactone significantly reduced cytokine production, compared to the same dose of alacepril or CV-11974. These findings indicate that spironolactone may contribute to ameliorate the prognosis of patients with cardiovascular diseases by reducing Ang II-induced inflammation, although further exploration including determining the mechanisms would be required.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available